| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA968574 | F | Cytotoxicity against human EPLC-272H cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 13 | ALA1149823 | cell-based format | Scientific Literature | |
| 2. | ALA979766 | F | Cytotoxicity against human EPLC-272H cells expressing wild type BRAF at 0.2 uM assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 1 | ALA1149823 | cell-based format | Scientific Literature | |
| 3. | ALA979767 | F | Cytotoxicity against human EPLC-272H cells expressing wild type BRAF at 2 uM assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 1 | ALA1149823 | cell-based format | Scientific Literature | |
| 4. | ALA2363209 | F | SANGER: Inhibition of human EPLC-272H cell growth in a cell viability assay. | Homo sapiens | 61 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 5. | ALA5161965 | F | Cytotoxicity against human EPLC-272H cells assessed as reduction of cell viability up to 10 uM incubated for 72 hrs by celltiter-glo assay | Homo sapiens | 1 | ALA5154806 | cell-based format | Scientific Literature | |
| 6. | ALA5262270 | F | Cytotoxicity against human EPLC-272H cells measured after 8 days | Homo sapiens | 3 | ALA5260810 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!